Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors.

Grimaldi AM, Simeone E, Festino L, Vanella V, Strudel M, Ascierto PA.

Am J Clin Dermatol. 2017 Dec;18(6):745-754. doi: 10.1007/s40257-017-0292-y. Review.

PMID:
28537004
2.

Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity.

Inno A, Metro G, Bironzo P, Grimaldi AM, Grego E, Di Nunno V, Picasso V, Massari F, Gori S.

Tumori. 2017 Sep 18;103(5):405-421. doi: 10.5301/tj.5000625. Epub 2017 May 10. Review.

PMID:
28497847
3.

Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis.

Di Monta G, Caracò C, Simeone E, Grimaldi AM, Marone U, Di Marzo M, Vanella V, Festino L, Palla M, Mori S, Mozzillo N, Ascierto PA.

J Transl Med. 2017 Apr 26;15(1):82. doi: 10.1186/s12967-017-1186-8.

4.

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma.

Simeone E, Grimaldi AM, Festino L, Giannarelli D, Vanella V, Palla M, Curvietto M, Esposito A, Palmieri G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2017 Jan 19;6(3):e1283462. doi: 10.1080/2162402X.2017.1283462. eCollection 2017.

PMID:
28405510
5.

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients.

Tallerico R, Cristiani CM, Staaf E, Garofalo C, Sottile R, Capone M, Pico de Coaña Y, Madonna G, Palella E, Wolodarski M, Carannante V, Mallardo D, Simeone E, Grimaldi AM, Johansson S, Frumento P, Gulletta E, Anichini A, Colucci F, Ciliberto G, Kiessling R, Kärre K, Ascierto PA, Carbone E.

Oncoimmunology. 2016 Dec 7;6(2):e1261242. doi: 10.1080/2162402X.2016.1261242. eCollection 2017.

PMID:
28344869
6.

A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy.

Itchins M, Ascierto PA, Menzies AM, Oatley M, Lo S, Douraghi-Zadeh D, Harrington T, Maher R, Grimaldi AM, Guminski A.

Melanoma Res. 2017 Jun;27(3):243-250. doi: 10.1097/CMR.0000000000000343.

PMID:
28230715
7.

Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of Care.

Simeone E, Grimaldi AM, Festino L, Vanella V, Palla M, Ascierto PA.

BioDrugs. 2017 Feb;31(1):51-61. doi: 10.1007/s40259-016-0208-z. Review.

PMID:
28058658
8.

Response by Grimaldi et al to Letter Regarding Article, "Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives".

Grimaldi A, Mocumbi AO, Narayanan K, Marijon E.

Circulation. 2016 Nov 15;134(20):e463. No abstract available.

9.

Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial.

Ascierto PA, Vanella V, Grimaldi AM, Lucia F, Palla M, Simeone E, Mozzillo N.

Cancer Immunol Immunother. 2016 Nov;65(11):1395-1400. Epub 2016 Sep 7.

PMID:
27604993
10.

Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives.

Grimaldi A, Mocumbi AO, Freers J, Lachaud M, Mirabel M, Ferreira B, Narayanan K, Celermajer DS, Sidi D, Jouven X, Marijon E.

Circulation. 2016 Jun 14;133(24):2503-15. doi: 10.1161/CIRCULATIONAHA.115.021178. Review.

11.

Single versus combination immunotherapy drug treatment in melanoma.

Grimaldi AM, Marincola FM, Ascierto PA.

Expert Opin Biol Ther. 2016;16(4):433-41. doi: 10.1517/14712598.2016.1128891. Epub 2016 Feb 6. Review.

PMID:
26642234
12.

Prognostic Impact and Late Evolution of Untreated Moderate (2/4+) Functional Tricuspid Regurgitation in Patients Undergoing Aortic Valve Replacement.

Taramasso M, Maisano F, De Bonis M, Pozzoli A, Schiavi D, Benussi S, Grimaldi A, La Canna G, Alfieri O.

J Card Surg. 2016 Jan;31(1):9-14. doi: 10.1111/jocs.12656. Epub 2015 Nov 8.

PMID:
26549799
13.

Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathway.

Grimaldi AM, Simeone E, Festino L, Vanella V, Palla M, Ascierto PA.

Discov Med. 2015 Jun;19(107):455-61. Review.

14.

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.

Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G, Camerlingo R, Capone M, Madonna G, Festino L, Caracò C, Di Monta G, Marone U, Di Marzo M, Grimaldi AM, Mori S, Ciliberto G, Ascierto PA.

Oncoimmunology. 2015 May 22;4(6):e1008842. eCollection 2015 Jun.

15.

Clinicopathologic features and surgical management of primary umbilical melanoma: a case series.

Di Monta G, Caracò C, Marone U, Grimaldi AM, Anniciello AM, Di Marzo M, Simeone E, Mori S.

BMC Res Notes. 2015 Apr 15;8:147. doi: 10.1186/s13104-015-1096-x.

16.

Access to cardiac surgery in sub-Saharan Africa.

Mirabel M, Grimaldi A, Freers J, Jouven X, Marijon E.

Lancet. 2015 Feb 14;385(9968):606. doi: 10.1016/S0140-6736(15)60235-5. No abstract available.

PMID:
25706083
17.

Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis.

Ielasi A, Latib A, Sacco FM, Costopoulos C, Figini F, Grimaldi A, Naim C, Maisano F, Chieffo A, Montorfano M, Alfieri O, Colombo A.

J Cardiovasc Med (Hagerstown). 2015 Apr;16(4):286-95. doi: 10.2459/JCM.0000000000000249.

18.

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report.

Grimaldi AM, Simeone E, Palla M, Festino L, Caracò C, Mozzillo N, Petrillo A, Muto P, Ascierto PA.

Anticancer Drugs. 2015 Apr;26(4):464-8. doi: 10.1097/CAD.0000000000000206.

PMID:
25622086
19.

Neck mass in rural Africa.

Grimaldi A, Kakande B, Narayanan K, Sebatta E, Trucco G, Mirabel M, Ducloux R, Okello E, Marijon E.

Am J Med. 2015 Feb;128(2):e3-4. doi: 10.1016/j.amjmed.2014.10.018. Epub 2014 Oct 19. No abstract available.

PMID:
25448170
20.

Heart surgery for immigrants in Italy: burden of cardiovascular disease, adherence to treatment and outcomes.

Grimaldi A, Vermi AC, Cammalleri V, Castiglioni A, Pappalardo F, Taramasso M, Baratto F, Alfieri O.

J Cardiovasc Med (Hagerstown). 2016 Feb;17(2):105-12. doi: 10.2459/JCM.0000000000000228.

PMID:
25415358

Supplemental Content

Loading ...
Support Center